Leber Congenital Amaurosis 5 (LCA5) Peptide
-
- Target See all LCA5 products
- LCA5 (Leber Congenital Amaurosis 5 (LCA5))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- FSLQKLKEIS EARHLPERDD LAKKLVSAEL KLDDTERRIK ELSKNLELST
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of LCA5 antibody,
Alternative Names: LCA5 control peptide, LCA5 antibody Blocking Peptide, Anti-LCA5 Blocking Peptide, Leber Congenital Amaurosis 5 Blocking Peptide, C6orf152 Blocking Peptide, LCA5, LCA-5, LCA 5, LCA-5 Blocking Peptide, LCA 5 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- LCA5 (Leber Congenital Amaurosis 5 (LCA5))
- Synonyms
- C6orf152 Peptide, RGD1308555 Peptide, 4930431B11Rik Peptide, 5730406O13Rik Peptide, AV274874 Peptide, ORF64 Peptide, LCA5, lebercilin Peptide, Leber congenital amaurosis 5 Peptide, Leber congenital amaurosis 5 (human) Peptide, LCA5 Peptide, LOC787523 Peptide, Lca5 Peptide
- Background
- LCA5 is a protein that is thought to be involved in centrosomal or ciliary functions. Mutations in this gene cause Leber congenital amaurosis type V. Mutations in this gene cause Leber congenital amaurosis type V. Alternative splicing results in two transcript variants.
- Molecular Weight
- 80 kDa
-